Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Kidney Medicine
|
January 23, 2023
Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences
David Collister, Mark Farrar, Lesha Farrar, et al.
The Journal of Rheumatology
|
June 17, 2015
Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12
Sibel Zehra Aydin, Haner Direskeneli, Antoine Sreih, et al.
The Journal of Rheumatology
|
April 3, 2017
Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016
Gulen Hatemi, Alexa Meara, Yesim Ozguler, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2024
Cardiovascular toxicities associated with bispecific T-cell engager therapy
Ahmed Sayed, Malak Munir, Sanam M Ghazi, et al.
Cancer Immunology, Immunotherapy : CII
|
October 7, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Tyler C Haddad, Songzhu Zhao, Mingjia Li, et al.
The Journal of Rheumatology
|
March 17, 2019
Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018
Sibel Z Aydin, Joanna C Robson, Antoine G Sreih, et al.
Journal of Cancer Research and Clinical Oncology
|
September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
Abdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)
Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Kidney Medicine
|
January 23, 2023
Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences
David Collister, Mark Farrar, Lesha Farrar, et al.
The Journal of Rheumatology
|
June 17, 2015
Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12
Sibel Zehra Aydin, Haner Direskeneli, Antoine Sreih, et al.
The Journal of Rheumatology
|
April 3, 2017
Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016
Gulen Hatemi, Alexa Meara, Yesim Ozguler, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2024
Cardiovascular toxicities associated with bispecific T-cell engager therapy
Ahmed Sayed, Malak Munir, Sanam M Ghazi, et al.
Cancer Immunology, Immunotherapy : CII
|
October 7, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Tyler C Haddad, Songzhu Zhao, Mingjia Li, et al.
The Journal of Rheumatology
|
March 17, 2019
Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018
Sibel Z Aydin, Joanna C Robson, Antoine G Sreih, et al.
Journal of Cancer Research and Clinical Oncology
|
September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
Abdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)
Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Page
of 5